Combipatch and bone density decreased 
Combipatch and bone density decreased Patient Reports February 10, 2012
Combipatch Side Effects Report #5382538-6
Combipatch side effect was reported by a Consumer or non-health professional from UNITED STATES on June 29, 2007. Female patient, 66 years of age, weighting 125.0 lb, was diagnosed with menopause
and was treated with Combipatch. After drug was administered, patient experienced the following side effects: anxiety , blood cholesterol increased, blood thyroid stimulating hormone increased, bone density decreased, breast cancer , breast disorder, breast mass, cataract , cataract operation. Combipatch dosage: unknown. During the same period patient was treated with PROVERA, ESTRADERM, VIVELLE, AYGESTIN, ESTRATEST, PREMARIN. Patient was hospitalized. Patient recovered.Combipatch Side Effects Report #5378118-9
Combipatch side effect was reported by a Consumer or non-health professional from UNITED STATES on June 20, 2007. Female patient, 57 years of age, weighting 150.0 lb, was diagnosed with menopause
and was treated with Combipatch. After drug was administered, patient experienced the following side effects: biopsy, bone density decreased, breast cancer in situ, depression , erythema, hot flush, ligament sprain, malignant breast lump removal. Combipatch dosage: unknown. During the same period patient was treated with ORAL CONTRACEPTIVE NOS, PREMPRO, ESTRATEST, PROVERA, TAMOXIFEN CITRATE, ARIMIDEX, ESTRACE. Patient recovered.Combipatch Side Effects Report #5816005-X
Combipatch side effect was reported by a Consumer or non-health professional from UNITED STATES on July 14, 2008. Female patient, weighting 145.0 lb, was diagnosed with menopause
and was treated with Combipatch. After drug was administered, patient experienced the following side effects: aspiration breast, biopsy, blister, bone density decreased, breast cancer in situ, breast mass, chest injury. Combipatch dosage: unknown. During the same period patient was treated with ORAL CONTRACEPTIVE NOS, PREMPRO, ESTRATEST, PROVERA, MEDROXYPROGESTERONE, FEMHRT, ESTRACE, ESTRADIOL. Patient recovered.Combipatch Side Effects Report #5828966-3
Combipatch side effect was reported by a Consumer or non-health professional from UNITED STATES on July 21, 2008. Female patient, weighting 125.0 lb, was diagnosed with menopause
, cardiovascular event prophylaxis, bone disorder, hot flush, vulvovaginal dryness and was treated with Combipatch. After drug was administered, patient experienced the following side effects: anxiety , blood cholesterol increased, blood thyroid stimulating hormone increased, blood triglycerides increased, bone density decreased, breast cancer , breast disorder, breast mass, cataract . Combipatch dosage: 0.25 MG, UNK. During the same period patient was treated with ESTRADERM, VIVELLE, AYGESTIN. Patient was hospitalized. Patient recovered.Combipatch Side Effects Report #6038192-3
Combipatch side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 05, 2009. Female patient, weighting 125.0 lb, was diagnosed with menopause
, cardiovascular event prophylaxis, bone disorder, hot flush, vulvovaginal dryness and was treated with Combipatch. After drug was administered, patient experienced the following side effects: anxiety , atrophic vulvovaginitis, blood cholesterol increased, blood thyroid stimulating hormone increased, blood triglycerides increased, bone density decreased, breast cancer , breast disorder, breast mass. Combipatch dosage: 0.25 MG, UNK. During the same period patient was treated with ESTRADERM, VIVELLE, AYGESTIN. Patient was hospitalized. Patient recovered.Combipatch Side Effects Report #6054939-4
Combipatch side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 23, 2009. Female patient, weighting 125.0 lb, was diagnosed with menopause
, cardiovascular event prophylaxis, bone disorder, hot flush, vulvovaginal dryness and was treated with Combipatch. After drug was administered, patient experienced the following side effects: anxiety , atrophic vulvovaginitis, blood cholesterol increased, blood thyroid stimulating hormone increased, blood triglycerides increased, bone density decreased, breast cancer , breast disorder, breast mass. Combipatch dosage: 0.25 MG, UNK. During the same period patient was treated with ESTRADERM, VIVELLE, AYGESTIN. Patient was hospitalized. Patient recovered.